表紙:核酸分離・精製の世界市場 (2021-2031年):市場予測 (製品・エンドユーザー・地域/国別)・競合情勢
市場調査レポート
商品コード
1018460

核酸分離・精製の世界市場 (2021-2031年):市場予測 (製品・エンドユーザー・地域/国別)・競合情勢

Global Nucleic Acid Isolation and Purification Market: Focus on Product, End User, Region/Country Data and Competitive Landscape - Analysis and Forecast, 2021-2031

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 395 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.65円
核酸分離・精製の世界市場 (2021-2031年):市場予測 (製品・エンドユーザー・地域/国別)・競合情勢
出版日: 2021年07月09日
発行: BIS Research Inc.
ページ情報: 英文 395 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の核酸分離・精製の市場規模は予測期間中7.20%のCAGRで推移し、2031年には50億1030万米ドルの規模に成長すると予測されています。

遺伝子検査数の増加、信頼性の高い次世代シーケンサー(NGS)の結果に対する需要の高まり、感染症の有病率の上昇、分子生物学分野の研究資金の増加、世界レベルでの個別化医療に対する意識と受容の高まりなどの要因が同市場の成長を推進しています。一方で、ゲノムデータの保護、オートメーション機器の高コスト性、厳格な規制基準などの課題が市場のさらなる成長を妨げる要因となっています。

当レポートでは、世界の核酸分離・精製の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、製品・用途・技術・地域など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 製品の定義

第2章 調査範囲

第3章 調査手法

第4章 市場概要

  • 定義
  • 核酸分離・精製の自動化用途
    • ゲノム/プラスミドDNA抽出
    • セルフリーDNA(cfDNA)抽出
    • ウイルスRNA抽出
    • セルフリーRNA抽出
  • 市場規模・成長の可能性
  • 市場の魅力:マクロ&ミクロ因子の分析
  • COVID-19の影響
  • 市場力学
  • 影響分析
  • 市場推進因子
  • 市場抑制因子
  • 市場機会

第5章 産業考察

  • 主な展開
  • 産業動向

第6章 核酸分離・精製市場:エンドユーザー・価格分析

第7章 核酸分離・精製市場の分析・予測:製品別

  • 消耗品
    • キット
    • 試薬
  • 機器

第8章 核酸分離・精製キット部門の分析・予測

  • ワークフロー別
    • サンプル分離・抽出・精製
    • DNA/RNAのクリーンアップ・濃縮
    • DNA・RNAの定量化
  • 検体別
    • DNA
    • RNA

第9章 DNA分離・精製キット部門の分析・予測:原料別

  • セルフリー
    • 検体別
    • 用途別
  • ゲノム
    • 血液
    • 体液
    • 細胞・培養細胞
    • FFPE
    • 法医学
    • 植物
    • 唾液・綿棒
    • 血清・血漿
    • 組織
    • 便・尿・その他
  • 微生物
    • バクテリア
    • 真菌
    • 酵母
    • その他
  • プラスミド
    • GigaPrep
    • MaxiPrep
    • MegaPrep
    • MidiPrep
    • MiniPrep
  • ウイルス

第10章 RNA分離・精製キット部門の分析・予測:原料別

  • ゲノムRNA
    • 血液
    • 体液
    • 細胞・培養細胞
    • FFPE
    • 植物
    • 唾液・綿棒
    • 血清・血漿
    • 組織
    • 尿
    • その他
  • 微生物RNA
    • バクテリア
    • 酵母
    • 真菌
    • その他
  • ウイルスRNA
  • セルフリーRNA
    • 血清/血漿
    • その他

第11章 核酸分離・精製用消耗品部門の分析・予測:技術別

  • シリカベース
  • 磁性粒子技術
  • その他

第12章 核酸分離・精製用消耗品部門の分析・予測:下流用途別

  • PCR
  • qPCR
  • NGS
  • クローニング
  • マイクロアレイ
  • ブロッティング技術
  • その他

第13章 核酸分離・精製用消耗品部門の分析・予測:エンドユーザー別

  • 学術調査機関・ラボ
  • 製薬・バイオテクノロジー企業
  • CRO
  • 応用試験
  • 臨床診断センター

第14章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州・中東・アフリカ
  • ラテンアメリカ
  • アジア太平洋

第15章 核酸分離・精製機器部門の分析・予測

  • ワークフロー別
    • 分離/抽出/精製
    • 品質管理/定量化
  • 技術別
    • 自動スピンカラムベース
    • 磁気ビーズベース
    • 自動液体処理
  • スループット別
    • 低スループット機器
    • 中スループット機器
    • ハイスループット機器
  • 品質管理/定量化機器:技術別
    • 分光光度計
    • 蛍光光度計
    • その他
  • エンドユーザー別
    • 学術研究機関
    • 製薬・バイオテクノロジー企業
    • 臨床診断センター
    • 応用試験(バイオバンク・法医学・獣医ラボ)
    • CRO
  • 地域別
    • 北米
    • 欧州・中東・アフリカ
    • アジア太平洋
    • ラテンアメリカ

第16章 競合情勢

  • 市場シェア分析
  • 成長シェアマトリックス:エンドユーザー別
  • 成長シェアマトリックス:地域別
  • 成長シェアマトリックス:製品別

第17章 戦略的提言

  • 要点
  • ギャップ分析
  • 事業拡大機会のマッピング
  • 投資機会
  • SWOT分析
  • 成功戦略

第18章 企業プロファイル

  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • AutoGen, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Macherey-Nagel GmbH & Co KG
  • New England Biolabs, Inc
  • Norgen Biotek Corp.
  • Omega Bio-tek, Inc.
  • Orasure Technologies, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Sage Science, Inc.
  • Tecan Group
  • ThermoFisher Scientific Inc.
  • Zymo Research
  • Emerging Companies
図表

List of Tables

  • Table 4.1: Likert Scale
  • Table 4.2: Impact Analysis of Market Drivers
  • Table 4.3: Impact Analysis of Market Restraints
  • Table 4.4: Other Key Research Funding for Nucleic Acid Extraction
  • Table 5.1: Commercially Available CTC Isolation Technologies
  • Table 5.2: Key Market Players Offering Ultra Pure Extraction Kits
  • Table 6.1: Key Automated DNA Extraction/Isolation/Purification and Quantification/Quality Control Systems Price and Material Cost per Sample
  • Table 6.2: Pricing of Market Available Consumables
  • Table 11.1: Other Technologies Consumables Market, $Million, 2020-2031
  • Table 13.1: Academic Research Institutes and Laboratories Consumables Market (by Analyte), $Million, 2020-2031
  • Table 13.2: Pharmaceutical and Biotechnology Companies Consumables Market (by Analyte), $Million, 2020-2031
  • Table 13.3: Contract Research Organizations Consumables Market (by Analyte), $Million, 2020-2031
  • Table 13.4: Applied Testing Consumables Market, (by Analyte) $Million, 2020-2031
  • Table 13.5: Clinical Diagnostic Center Consumables Market (by Analyte), $Million, 2020-2031
  • Table 14.1: Global Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2020-2031
  • Table 14.2: Global DNA Isolation and Purification Kits Market (by Region), $Million, 2020-2031
  • Table 14.3: Global RNA Isolation and Purification Kits Market (by Region), $Million, 2020-2031
  • Table 14.4: Global Nucleic Acid Isolation and Purification Reagents Market (by Region), $Million, 2020-2031
  • Table 14.5: North America Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2020-2031
  • Table 14.6: North America DNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
  • Table 14.7: North America RNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
  • Table 14.8: EMEA Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2020-2031
  • Table 14.9: EMEA Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2020-2031
  • Table 14.10: EMEA DNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
  • Table 14.11: EMEA RNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
  • Table 14.12: LATAM Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2020-2031
  • Table 14.13: LATAM Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2020-2031
  • Table 14.14: LATAM DNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
  • Table 14.15: LATAM RNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
  • Table 14.16: APAC Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2020-2031
  • Table 14.17: APAC Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2020-2031
  • Table 14.18: APAC DNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
  • Table 14.19: APAC RNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
  • Table 15.1: Key Isolation/Extraction/Purification Systems for Nucleic Acids
  • Table 15.2: Key Quality Control/Quantification Systems for Nucleic Acids
  • Table 15.3: Key Column-Based Systems for Nucleic Acid Extraction
  • Table 15.4: Key Magnetic Bead-Based Systems for Nucleic Acid Extraction
  • Table 15.5: Key Automated Liquid Handling Instruments for Nucleic Acid Extraction
  • Table 15.6: Key Low Throughput Systems for Nucleic Acid Extraction
  • Table 15.7: Key Medium Throughput Systems for Nucleic Acid Extraction
  • Table 15.8: Key High Throughput Systems for Nucleic Acid Extraction
  • Table 15.9: Key Spectrophotometer Systems for Quality Control/Quantification
  • Table 15.10: Key Fluorometers Systems for Quality Control/Quantification
  • Table 15.11: Key Other Systems for Quality Control/Quantification
  • Table 15.12: Collaborations in Genetics and Genomics Research in Africa, by Funder
  • Table 17.1: Major Issues in Research Laboratories in the Asia-Pacific Region
  • Table 17.2: Funding Scenario in the Competitive Genomic Landscape

List of Figures

  • Figure 1: Cumulative Number of Tested Conditions and Associated Genes for Genetic Testing, 2012-2019
  • Figure 2: Impact Analysis on the Global Nucleic Acid Isolation and Purification Market
  • Figure 3: Nucleic Acid Isolation and Purification Market, (by Product), $Million, 2020 vs. 2031
  • Figure 4: Nucleic Acid Isolation and Purification Consumables Market, (by Type), $Million, 2020 vs. 2031
  • Figure 5: Nucleic Acid Isolation and Purification Consumables Market, (by Technology), $Million, 2020 vs. 2031
  • Figure 6: Nucleic Acid Isolation and Purification Consumables Market, (by End User), $Million, 2020 vs. 2031
  • Figure 7: Global Nucleic Acid Isolation and Purification Consumables Market Snapshot, (by Region) 2020 and 2031
  • Figure 8: Nucleic Acid Isolation and Purification Instrument Market, (by Technology), $Million, 2020 vs. 2031
  • Figure 9: Nucleic Acid Isolation and Purification Instrument Market, (by Throughput), $Million, 2020 vs. 2031
  • Figure 10: Global Nucleic Acid Isolation and Purification Instrument Market Snapshot, (by Region)
  • Figure 2.1: Global Nucleic Acid Isolation and Purification Market Segmentation
  • Figure 3.1: Global Nucleic Acid Isolation and Purification Market Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Forecast Methodology
  • Figure 4.1: North America Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
  • Figure 4.2: EMEA Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
  • Figure 4.3: Asia-Pacific Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
  • Figure 4.4: Latin America Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
  • Figure 4.5: Market Attractiveness Based on Key Characteristics
  • Figure 4.6: Impact of COVID-19 on the Global Nucleic Acid Isolation and Purification Market
  • Figure 4.5: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
  • Figure 4.6: Key Genetic Disorder Prevalence in the U.S., 2012-2017
  • Figure 5.1: Share of Key Developments and Strategies
  • Figure 6.1: Nucleic Acid Isolation and Purification Customer Preference (by Major Brand), N=27
  • Figure 6.2: Nucleic Acid Isolation and Purification Customer Satisfaction Level (5 Being the Highest) (by Brand) (N=27)
  • Figure 7.1: Nucleic Acid Isolation and Purification Market (by Product), $Million, 2020 and 2031
  • Figure 7.2: Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 7.3: Nucleic Acid Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 7.4: Nucleic Acid Isolation and Purification Reagents Market, $Million, 2020-2031
  • Figure 7.5: Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 8.1: Nucleic Acid Isolation and Purification Kits Market (by Workflow), $Million, 2020 and 2031
  • Figure 8.2: Sample Isolation/Extraction/Purification Kits Market, $Million, 2020-2031
  • Figure 8.3: DNA/RNA Clean-Up and concentration Kits Market, $Million, 2020-2031
  • Figure 8.4: DNA and RNA Quantification Kits Market, $Million, 2020-2031
  • Figure 8.5: Nucleic Acid Isolation and Purification Kits Market (by Analyte), $Million, 2020 and 2031
  • Figure 8.6: DNA Kits Market, $Million, 2020-2031
  • Figure 8.7: Market Share for DNA Kits Market, $Million, 2020
  • Figure 8.8: RNA Kits Market, $Million, 2020-2031
  • Figure 8.9: Market Share for RNA Kits Market, $Million, 2020
  • Figure 9.1: DNA Isolation and Purification Kits Market (by Source Type), $Million, 2020 and 2031
  • Figure 9.2: Cell-Free DNA Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.3: Market Share for Cell-Free DNA Isolation and Purification Kits Market, $Million, 2020
  • Figure 9.4: Cell-Free DNA Isolation and Purification Kits Market for Blood, $Million, 2020-2031
  • Figure 9.5: Cell-Free DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2020-2031
  • Figure 9.6: Cell-Free DNA Isolation and Purification Kits Market for Other Sources, $Million, 2020-2031
  • Figure 9.7: Cell-Free DNA Isolation and Purification Kits Market for Prenatal and Hereditary Testing, $Million, 2020-2031
  • Figure 9.8: Cell-Free DNA Isolation and Purification Kits Market for Tumor Testing, $Million, 2020-2031
  • Figure 9.9: Cell-Free DNA Isolation and Purification Kits Market for Transplantation, $Million, 2020-2031
  • Figure 9.10: Genomic DNA Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.11: Market Share for Genomic DNA Isolation and Purification Kits Market, $Million, 2020
  • Figure 9.12: Genomic DNA Isolation and Purification Kits Market for Blood, $Million, 2020-2031
  • Figure 9.13: Market Share for Genomic DNA Isolation and Purification Market for Blood, $Million, 2020
  • Figure 9.14: Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, 2020-2031
  • Figure 9.15: Market Share for Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, (2020)
  • Figure 9.16: Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2020-2031
  • Figure 9.17: Market Share for Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2020
  • Figure 9.18: Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2020-2031
  • Figure 9.19: Market Share for Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2020
  • Figure 9.20: Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2020-2031
  • Figure 9.21: Market Share for Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2020
  • Figure 9.22: Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2020-2031
  • Figure 9.23: Market Share for Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2020
  • Figure 9.24: Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2020-2031
  • Figure 9.25: Market Share for Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2020
  • Figure 9.26: Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2020-2031
  • Figure 9.27: Market Share for Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2020
  • Figure 9.28: Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2020-2031
  • Figure 9.29: Market Share for Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2020
  • Figure 9.30: Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2020-2031
  • Figure 9.31: Market Share for Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2020
  • Figure 9.32: Genomic DNA Isolation and Purification Kits Market for Combined Segment, $Million, 2020-2031
  • Figure 9.33: Market Share for Genomic DNA Isolation and Purification Kits Market for Stool, Urine, and Other Samples, $Million, 2020
  • Figure 9.34: Microbe DNA Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.35: Market Share for Microbe DNA Isolation and Purification Kits Market, $Million, 2020
  • Figure 9.36: Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2020-2031
  • Figure 9.37: Market Share for Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2020
  • Figure 9.38: Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2020-2031
  • Figure 9.39: Market Share for Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2020
  • Figure 9.40: Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2020-2031
  • Figure 9.41: Market Share for Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2020
  • Figure 9.42: Microbial DNA Isolation and Purification Kits Market for Other Sources, $Million, 2020-2031
  • Figure 9.43: Plasmid DNA Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.44: Market Share for Plasmid DNA Isolation and Purification Kits Market, $Million, 2020
  • Figure 9.45: Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.46: Market Share for Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2020
  • Figure 9.47: Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.48: Market Share for Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2020
  • Figure 9.49: Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.50: Market Share for Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2020
  • Figure 9.51: Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.52: Market Share for Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2020
  • Figure 9.53: Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.54: Market Share for Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2020
  • Figure 9.55: Viral DNA Isolation and Purification Kits Market, $Million, 2020-2031
  • Figure 9.56: Market Share for Viral DNA Isolation and Purification Kits Market, $Million, 2020
  • Figure 10.1: RNA Isolation and Purification Kits Market, $Million, 2020 and 2031
  • Figure 10.2: Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.3: Genomic RNA Kits Market Share, 2020
  • Figure 10.4: Genomic RNA Kits for Blood Market, $Million, 2020-2031
  • Figure 10.5: Genomic RNA Extraction Kits from Blood, Market Share, 2020
  • Figure 10.6: Body Fluids Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.7: Cell/Cultured Cell Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.8: Cell/Cultured Cell Genomic RNA Extraction Kits, Market Share, 2020
  • Figure 10.9: FFPE Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.10: FFPE Genomic RNA Extraction Kits, Market Share, 2020
  • Figure 10.11: Plant Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.12: Plant Genomic RNA Extraction Kits, Market Share, 2020
  • Figure 10.13: Saliva/Swab Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.14: Serum/Plasma Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.15: Serum/Plasma Genomic RNA Extraction Kits, Market Share, 2020
  • Figure 10.16: Tissue Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.17: Tissue Genomic RNA Extraction Kits, Market Share, 2020
  • Figure 10.18: Urine Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.19: Other Genomic RNA Kits Market, $Million, 2020-2031
  • Figure 10.20: Microbial RNA Kits Market, $Million, 2020-2031
  • Figure 10.21: Microbial RNA Kits Market Share, 2020
  • Figure 10.22: Bacterial RNA Kits Market, $Million, 2020-2031
  • Figure 10.23: Bacterial RNA Kits Market Share, 2020
  • Figure 10.24: Yeast RNA Kits Market, $Million, 2020-2031
  • Figure 10.25: Yeast RNA Kits Market Share, 2020
  • Figure 10.26: Fungus RNA Kits Market, $Million, 2020-2031
  • Figure 10.27: Fungal RNA Kits Market Share, 2020
  • Figure 10.28: Other Microbial RNA Kits Market, $Million, 2020-2031
  • Figure 10.29: Viral RNA Kits Market, $Million, 2020-2031
  • Figure 10.30: Viral RNA Kits Market Share, 2020
  • Figure 10.31: Cell-Free RNA Kits Market, $Million, 2020-2031
  • Figure 10.32: cell-free RNA Kits Market Share, 2020
  • Figure 10.33: Serum/Plasma Cell-Free RNA Kits Market, $Million, 2020-2031
  • Figure 10.34: Other Cell-Free RNA Kits Market, $Million, 2020-2031
  • Figure 11.1: Nucleic Acid Isolation and Purification Consumables Market (by Technology), $Million, 2020 and 2031
  • Figure 11.2: Silica-Based Consumables Market, $Million, 2020-2031
  • Figure 11.3: Magnetic Particle-based Consumables Market, $Million, 2020-2031
  • Figure 12.1: Nucleic Acid Isolation and Purification Consumables Market (by Technological Downstream Applications), $Million, 2020 and 2031
  • Figure 12.2: PCR Market, $Million, 2020-2031
  • Figure 12.3: qPCR Market, $Million, 2020-2031
  • Figure 12.4: NGS Market, $Million, 2020-2031
  • Figure 12.5: Cloning Market, $Million, 2020-2031
  • Figure 12.6: Microarray Market, $Million, 2020-2031
  • Figure 12.7: Blotting Techniques Market, $Million, 2020-2031
  • Figure 12.8: Other Applications Market, $Million, 2020-2031
  • Figure 13.1: Nucleic Acid Isolation and Purification Consumables Market (by End User), $Million, 2020 and 2031
  • Figure 13.2: Academic Research Institutes and Laboratories Market, $Million, 2020-2031
  • Figure 13.3: Pharmaceutical and Biotechnology Companies Market, $Million, 2020-2031
  • Figure 13.4: Contract Research Organizations Market, $Million, 2020-2031
  • Figure 13.5: Applied Testing Market, $Million, 2020-2031
  • Figure 13.6: Clinical Diagnostic Center Market, $Million, 2020-2031
  • Figure 14.1: Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2020 and 2031
  • Figure 14.2: North America Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 14.3: U.S. Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 14.4: Canada Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 14.5: EMEA Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 14.6: LATAM Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 14.7: APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 14.8: China Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 14.9: Japan Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 14.10: Rest-of-APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
  • Figure 15.1: Nucleic Acid Isolation and Purification Instrument Market (by Workflow), $Million, 2020 and 2031
  • Figure 15.2: Isolation/Extraction/Purification Instrument Market, $Million, 2020-2031
  • Figure 15.3: Quality Control/Quantification Instrument Market, $Million, 2020-2031
  • Figure 15.4: Nucleic Acid Extraction/Isolation/Purification Instrument Market (by Technology), $Million, 2020 and 2031
  • Figure 15.5: Automated Spin Column-Based Instrument Market, $Million, 2020-2031
  • Figure 15.6: Magnetic Bead-based Instrument Market, $Million, 2020-2031
  • Figure 15.7: Automated Liquid Handling Instruments Market, $Million, 2020-2031
  • Figure 15.8: Nucleic Acid Extraction/Isolation/Purification Instrument Market (by Throughput), $Million, 2020 and 2031
  • Figure 15.9: Low Throughput Instrument Market, $Million, 2020-2031
  • Figure 15.10: Medium Throughput Instrument Market, $Million, 2020-2031
  • Figure 15.11: High Throughput Instrument Market, $Million, 2020-2031
  • Figure 15.12: Quality Control/Quantification Instruments, (by Technology), $Million, 2020 and 2031
  • Figure 15.13: Spectrophotometers Market, $Million, 2020-2031
  • Figure 15.14: Fluorometers Market, $Million, 2020-2031
  • Figure 15.15: Others Market, $Million, 2020-2031
  • Figure 15.16: Nucleic Acid Isolation and Purification Instrument Market (by End User), $Million, 2020 and 2031
  • Figure 15.17: Nucleic Acid Isolation and Purification Instrument Market for Academic Research Institutes, $Million, 2020-2031
  • Figure 15.18: Nucleic Acid Isolation and Purification Instrument Market for Pharmaceutical and Biotechnology Companies, $Million, 2020-2031
  • Figure 15.19: Nucleic Acid Isolation and Purification Instrument Market for Clinical Diagnostic Centers, $Million, 2020-2031
  • Figure 15.20: Nucleic Acid Isolation and Purification Instrument Market for Applied Testing, $Million, 2020-2031
  • Figure 15.21: Nucleic Acid Isolation and Purification Instrument Market for Contract Research Organizations, $Million, 2020-2031
  • Figure 15.22: Nucleic Acid Isolation and Purification Instrument Market (by Region), $Million, 2020 and 2031
  • Figure 15.23: North America Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 15.24: North America Nucleic Acid Isolation and Purification Instrument Market (by Country), $Million, 2020-2031
  • Figure 15.25: U.S. Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 15.26: Canada Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 15.27: EMEA Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 15.28: APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 15.29: APAC Nucleic Acid Isolation and Purification Instrument Market (by Country) $Million, 2020-2031
  • Figure 15.30: China Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 15.31: Japan Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 15.32: Rest-of-APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 15.33: LATAM Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
  • Figure 16.1: Market Share Analysis for the Global Nucleic Acid Isolation and Purification (Instrument and Kits) Market, 2020
  • Figure 16.2: Market Share Analysis for the Global Nucleic Acid Isolation and Purification Instrument Market, 2020
  • Figure 16.3: Global Nucleic Acid Isolation and Purification Kits Market Share, 2020
  • Figure 16.4: Market Share Analysis for the North America Nucleic Acid Isolation and Purification (Instrument and Kits) Market, 2020
  • Figure 16.5: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Instrument Market, 2018
  • Figure 16.6: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Kits Market, 2020
  • Figure 16.7: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification (Instrument and Kits) Market, 2020
  • Figure 16.8: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Instrument Market, 2020
  • Figure 16.9: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Kits Market, 2020
  • Figure 16.10: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by End User)
  • Figure 16.11: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Region)
  • Figure 16.12: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Product)
  • Figure 17.1: Business Expansion Opportunity Mapping (by Product)
  • Figure 17.2: Business Expansion Opportunity Mapping (by Region)
  • Figure 17.3: Nucleic Acid Isolation and Purification Market: SWOT Analysis
  • Figure 18.1: Total Number of Companies Profiles
  • Figure 18.2: Agilent Technologies, Inc.: Key Product Portfolio
  • Figure 18.3: Agilent Technologies, Inc.: Overall Financials, 2018-2020
  • Figure 18.4: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
  • Figure 18.5: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
  • Figure 18.6: Agilent Technologies, Inc.: R&D Expenditure, 2018-2020
  • Figure 18.7: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 18.8: Analytik Jena AG: Key Product Portfolio
  • Figure 18.9: Analytik Jena AG: SWOT Analysis
  • Figure 18.10: AutoGen, Inc.: Key Product Portfolio
  • Figure 18.11: AutoGen, Inc.: SWOT Analysis
  • Figure 18.12: Bio-Rad Laboratories, Inc.: Key Product Portfolio
  • Figure 18.13: Bio-Rad Laboratories, Inc.: Overall Financials, 2018-2020
  • Figure 18.14: Bio-Rad Laboratories, Inc.: Sales (by Segment), $Million, 2018-2020
  • Figure 18.15: Bio-Rad Laboratories, Inc.: Sales (by Region), 2018-2020
  • Figure 18.16: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2018-2020
  • Figure 18.17: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 18.18: F. Hoffmann-La Roche AG: Key Product Portfolio
  • Figure 18.19: F. Hoffmann-La Roche AG: Overall Financials, 2018-2020
  • Figure 18.20: F. Hoffmann-La Roche AG: Revenue (by Segment), $Million, 2018-2020
  • Figure 18.21: F. Hoffmann-La Roche AG: Revenue (by Region), 2018-2020
  • Figure 18.22: F. Hoffmann-La Roche AG: R&D Expenditure, 2018-2020
  • Figure 18.23: F. Hoffmann-La Roche AG: SWOT Analysis
  • Figure 18.24: Illumina, Inc.: Key Product Portfolio
  • Figure 18.25: Illumina, Inc.: Overall Financials, 2018-2020
  • Figure 18.26: Illumina, Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 18.27: Illumina, Inc.: Revenue (by Region), 2018-2020
  • Figure 18.28: Illumina, Inc.: R&D Expenditure, 2018-2020
  • Figure 18.29: Illumina, Inc.: SWOT Analysis
  • Figure 18.30: Merck KGaA: Key Product Offerings
  • Figure 18.31: Merck KGaA: Overall Financials, 2018-2020
  • Figure 18.32: Merck KGaA: Revenue (by Segment), $Million, 2018-2020
  • Figure 18.33: Merck KGaA: Revenue (by Region), 2018-2020
  • Figure 18.34: Merck KGaA: R&D Expenditure, 2018-2020
  • Figure 18.35: Merck KGaA: SWOT Analysis
  • Figure 18.36: Meridian Bioscience: Key Product Portfolio
  • Figure 18.37: Meridian Bioscience: Overall Financials, 2018-2020
  • Figure 18.38: Meridian Bioscience Revenue (by Segment), 2018-2020
  • Figure 18.39: Meridian Bioscience: Revenue (by Region), 2018-2020
  • Figure 18.40: Meridian Bioscience: R&D Expenditure, 2018-2020
  • Figure 18.41: Meridian Bioscience: SWOT Analysis
  • Figure 18.42: Macherey-Nagel GmbH & Co KG: Key Product Portfolio
  • Figure 18.43: Macherey-Nagel GmbH & Co KG: SWOT Analysis
  • Figure 18.44: New England Biolabs, Inc: Key Product Offerings
  • Figure 18.45: New England Biolabs, Inc.: SWOT Analysis
  • Figure 18.46: Norgen Biotek Corp.: Key Product Portfolio
  • Figure 18.47: Norgen Biotek Corp.: SWOT Analysis
  • Figure 18.48: Omega Bio-tek, Inc.: Key Product Portfolio
  • Figure 18.49: Omega Bio-Tek: SWOT Analysis
  • Figure 18.50: Orasure Technologies, Inc.: Key Product Portfolio
  • Figure 18.51: Orasure Technologies, Inc.: Overall Financials, 2018-2020
  • Figure 18.52: Orasure Technologies, Inc. Revenue (by Segment), 2018-2020
  • Figure 18.53: Orasure Technologies, Inc.: Revenue (by Region), 2018-2020
  • Figure 18.54: Orasure Technologies, Inc.: R&D Expenditure, 2018-2020
  • Figure 18.55: Orasure Technologies, Inc.: SWOT Analysis
  • Figure 18.56: PerkinElmer, Inc.: Key Product Portfolio
  • Figure 18.57: Perkin Elmer, Inc.: Overall Financials, (2018-2020)
  • Figure 18.58: Perkin Elmer, Inc.: Revenue (by Business Segment), 2018-2020
  • Figure 18.59: Perkin Elmer, Inc.: Revenue (by Region), 2018-2020
  • Figure 18.60: PerkinElmer, Inc.: R&D Expenditure, 2018-2020
  • Figure 18.61: PerkinElmer, Inc.: SWOT Analysis
  • Figure 18.62: Promega Corporation: Key Product Portfolio
  • Figure 18.63: Promega Corporation: SWOT Analysis
  • Figure 18.64: QIAGEN N.V.: Key Product Offerings
  • Figure 18.65: QIAGEN N.V.: Overall Financials, 2018-2020
  • Figure 18.66: QIAGEN N.V.: Revenue (by Segment), 2018-2020
  • Figure 18.67: QIAGEN N.V.: Revenue (by Region), 2016-2018
  • Figure 18.68: QIAGEN N.V.: R&D Expenditure, 2018-2020
  • Figure 18.69: QIAGEN N.V.: SWOT Analysis
  • Figure 18.70: Sage Science, Inc.: Key Product Portfolio
  • Figure 18.71: Sage Science, Inc.: SWOT Analysis
  • Figure 18.72: Tecan Group: Key Product Portfolio
  • Figure 18.73: Tecan Group: Overall Financials, 2018-2020
  • Figure 18.74: Tecan Group Revenue (by Segment), 2018-2020
  • Figure 18.75: Tecan Group: Revenue (by Region), 2018-2020
  • Figure 18.76: Tecan Group: R&D Expenditure, 2018-2020
  • Figure 18.77: Tecan Group: SWOT Analysis
  • Figure 18.78: Thermo Fisher Scientific Inc.: Key Product Offerings
  • Figure 18.79: Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020
  • Figure 18.80: Thermo Fisher Scientific Inc: Sales (by Segment), $Million, 2018-2020
  • Figure 18.81: Thermo Fisher Scientific Inc.: Sales (by Region), 2018-2020
  • Figure 18.82: Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020
  • Figure 18.83: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 18.84: Zymo Research: Key Product Portfolio
  • Figure 18.85: Zymo Research: SWOT Analysis
目次
Product Code: BHP0827SB

“Global Nucleic Acid Isolation and Purification Market to Reach $5,010.3 Million by 2031.”

Market Report Coverage - Nucleic Acid Isolation and Purification

Market Segmentation

  • Product Type- Instruments and Consumables (Kits and Reagents)
  • End User - Academic Research Institutes and Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Applied Testing, Clinical Diagnostic Centers

Regional Segmentation

  • North America - U.S., Canada
  • Europe, Middle East & Africa (EMEA)
  • Asia-Pacific - China, Japan, and Rest-of-Asia-Pacific (RoAPAC)
  • Latin America (LATAM)

Market Growth Drivers

  • Growing Number of Genetic Tests
  • Increasing Demand for Reliable Next-Generation Sequencing (NGS) Results
  • Rise in the Prevalence of Infectious Disease
  • Rise in the Field of Microbial Sequencing
  • Increasing Research Funding in the Field of Molecular Biology
  • Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
  • Decreasing Cost of Sequencing

Market Challenges

  • Genomic Data Protection
  • High Cost of Automated Instruments
  • Rigid Regulatory Standards

Market Opportunities

  • Evolution of Biobanking in Healthcare
  • Capitalizing on the High Prevalence of Genetic Disorders
  • Growth in Emerging Nations
  • Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets

Key Companies Profiled

Agilent Technologies, Inc., Analytik Jena AG, AutoGen, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., Merck KGaA, Meridian Bioscience, Inc., Macherey-Nagel GmbH & Co KG, New England Biolabs, Inc, Norgen Biotek Corp., Omega Bio-tek, Inc., Orasure Technologies, Inc., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Sage Science, Inc., Tecan Group, ThermoFisher Scientific Inc., Zymo Research.

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global nucleic acid isolation and purification market?
  • What are the key development strategies which are being implemented by major players in order to sustain in the competitive market?
  • How each segment of the market is expected to grow during the forecast period from 2020 to 2031 based on
    • Product type: instrument and consumables (kits and reagents)
    • End User: academic research institutes, pharmaceutical and biotechnology companies, applied testing, contract research organizations, and clinical diagnostic centers
    • Region: North America, EMEA, Asia-Pacific, and Latin America
  • Which are the leading players with significant offerings to the global nucleic acid isolation and purification market? What is the expected market dominance for each of these leading players?
  • Which companies are anticipated to be highly disruptive in the future and why?
  • What are the challenges in the nucleic acid isolation and purification market?

Market Overview

BIS Research healthcare experts have found the nucleic acid isolation and purification market to be one of the growing markets, which is predicted to grow at a CAGR of 7.20% during the forecast period, 2021-2031. The nucleic acid isolation and purification market growth has been primarily attributed to the major drivers in this market, such as growing number of genetic tests, increasing demand for reliable next-generation sequencing (NGS) results, rise in the prevalence of infectious diseases, increasing research funding in the field of molecular biology, and increase in awareness and acceptance of personalized medicine on a global level. However, genomic data protection, high cost of automated instruments, and rigid regulatory standards are some of the factors expected to retrain the market growth.

The market is favored by the increased research activities based on next-generation sequencing-based technologies. The consumable segment has been segmented to into DNA and RNA sample type, among which RNA sample type is expected to growth at a highest CAGR of 7.70% during the forecast period 2021-2031. This increase is mainly attributed to the large number of research and development being conducted due to the COVID-19 pandemic, specifically considering viral RNA sample.

Within the research report, the market is segmented on the basis of product type, end users, and region. The kits segment is further segment into DNA and RNA, to gain holistic view of the industry. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the downstream application such as next-generation sequencing, polymerase chain reaction, and other techniques used for COVID-19 testing on the global level has created a buzz among companies to invest in the development of extraction RNA free severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests. Due to technologically advanced solutions and intense market penetration, companies such as Qiagen N.V., Promega Corporation, and Thermo Fisher Scientific, Inc. have been a pioneer and a significant competitor in this market.

Other key players in the market are: Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F.Hoffmann-La Roche AG, Illumina, Inc., General Electric Company (GE), and New England Biolabs, among others.

With the increasing demand for complex and custom sequencing techniques, rising genetic testing services, and growing research to treat and diagnose genetic and infectious diseases, companies have the opportunity to expand their product portfolios, increasing automation facilitation, and develop novel techniques for nucleic acid extraction by adopting different strategic approaches. Some of the strategies followed by the contributors are new product launches and enhancements, agreements, collaborations, partnerships, acquisitions, and expansions. For instance, in 2020, Promega Corporation has launched Wizard HMW DNA Extraction Kit for researchers working with large fragments of genomic DNA, which enables researchers to obtain DNA that will provide strong performance in long-read sequencing applications in a 90-minute manual protocol.

The nucleic acid isolation and purification market has immensely propelled by nationwide sequencing activities, focusing on generating large genomic libraries for research and development purpose. For instance, Illumina, Inc. has invested $60.0 million in sequencing capabilities to a global pathogen genomics initiative, in partnership with the Bill & Melinda Gates Foundation and other public and private entities. Under the contract, Illumina, Inc. will donate next-generation sequencing (NGS) platforms, reagents, and training support worth approximately US $60 million over five years.

Table of Contents

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Research Scope

  • 2.1 Scope of the Study

3 Research Methodology

  • 3.1 Global Nucleic Acid Isolation and Purification Market: Research Methodology
  • 3.2 Primary Data Sources
  • 3.3 Secondary Data Sources
  • 3.4 Market Estimation Model

4 Market Overview

  • 4.1 Definitions
    • 4.1.1 Product Definition
    • 4.1.2 Definition by Products
      • 4.1.2.1 Instruments
      • 4.1.2.2 Column-Based Instruments
      • 4.1.2.3 Bead-Based Instruments
      • 4.1.2.4 Low-Throughput Instruments
      • 4.1.2.5 Medium-Throughput Instruments
      • 4.1.2.6 High-Throughput Instruments
      • 4.1.2.7 Kits
      • 4.1.2.8 Reagents
  • 4.2 Nucleic Acid Isolation and Purification Automation Applications
    • 4.2.1 Genomic/Plasmid DNA Extraction
    • 4.2.2 Cell-Free DNA (cfDNA) Extraction
    • 4.2.3 Viral RNA Extraction
    • 4.2.4 Cell-Free RNA Extraction
  • 4.3 Market Size and Growth Potential, $Million, 2020-2031
    • 4.3.1 North America
    • 4.3.2 Europe, Middle East & Africa (EMEA)
    • 4.3.3 Asia-Pacific (APAC)
    • 4.3.4 Latin America
  • 4.4 Market Attractiveness: Macro and Micro Factor Analysis
  • 4.5 Impact of COVID-19 Pandemic on Nucleic Acid Isolation and Purification Market
  • 4.6 Market Dynamics
  • 4.7 Impact Analysis
  • 4.8 Market Drivers
    • 4.8.1 Growing Number of Genetic Tests
    • 4.8.2 Increasing Demand for Reliable Next-Generation Sequencing (NGS) Results
    • 4.8.3 Rise in the Prevalence of Infectious Disease
    • 4.8.4 Rise in the Field of Microbial Sequencing
    • 4.8.5 Increasing Research Funding in the Field of Molecular Biology
    • 4.8.6 Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
    • 4.8.7 Decreasing Cost of Sequencing
  • 4.9 Market Restraints
    • 4.9.1 Genomic Data Protection
    • 4.9.2 High Cost of Automated Instruments
    • 4.9.3 Rigid Regulatory Standards
  • 4.1 Market Opportunities
    • 4.10.1 Evolution of Biobanking in Healthcare
    • 4.10.2 Capitalizing on the High Prevalence of Genetic Disorders
    • 4.10.3 Growth in Emerging Nations
    • 4.10.4 Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets

5 Nucleic Acid Isolation and Purification Market: Industry Insights

  • 5.1 Key Developments
    • 5.1.1 Product Launches and Enhancements
    • 5.1.2 Collaborations and Agreements
    • 5.1.3 Acquisitions
    • 5.1.4 Business Expansions
  • 5.2 Industry Trends
    • 5.2.1 Emergence of Advanced Stabilization Products
    • 5.2.2 Regulated vs. Multimodal Analysis
    • 5.2.3 Novel Targets for Isolation and Purification
    • 5.2.4 Exploring New Applications
    • 5.2.5 Other Key Trends

6 Nucleic Acid Isolation and Purification Market: End User and Pricing Analysis

  • 6.1 Satisfaction Level of Different Instruments (by Brand)
  • 6.2 Pricing Analysis of Preferred Instruments
  • 6.3 Pricing Analysis - Accessories and Components
  • 6.4 Pricing Analysis - Consumables

7 Nucleic Acid Isolation and Purification Market (by Product), $Million, 2020-2031

  • 7.1 Introduction
  • 7.2 Consumables
    • 7.2.1 Kits
    • 7.2.2 Reagents
  • 7.3 Instruments

8 Nucleic Acid Isolation and Purification Kits Market, $Million, 2020-2031

  • 8.1 By Workflow
    • 8.1.1 Sample Isolation/Extraction/Purification
    • 8.1.2 DNA/RNA Clean-Up and Concentration
    • 8.1.3 DNA and RNA Quantification
  • 8.2 By Analyte
    • 8.2.1 DNA
    • 8.2.2 RNA

9 DNA Isolation and Purification Kits Market, (by Source Type) $Million, 2020-2031

  • 9.1 Cell-Free
    • 9.1.1 By Sample
      • 9.1.1.1 Blood
      • 9.1.1.2 Serum/Plasma
      • 9.1.1.3 Other Sources
    • 9.1.2 By Application
      • 9.1.2.1 Parental and Hereditary Testing
      • 9.1.2.2 Tumor Testing
      • 9.1.2.3 Transplantation
  • 9.2 Genomic
    • 9.2.1 Blood
    • 9.2.2 Body Fluids
    • 9.2.3 Buccal
    • 9.2.4 Cell/Cultured Cell
    • 9.2.5 FFPE
    • 9.2.6 Forensic
    • 9.2.7 Plant
    • 9.2.8 Saliva/Swab
    • 9.2.9 Serum/Plasma
    • 9.2.10 Tissue
    • 9.2.11 Stool, Urine, and Other Samples
  • 9.3 Microbe
    • 9.3.1 Bacterial
    • 9.3.2 Fungus
    • 9.3.3 Yeast
    • 9.3.4 Other Sources
  • 9.4 Plasmid
    • 9.4.1 GigaPrep
    • 9.4.2 MaxiPrep
    • 9.4.3 MegaPrep
    • 9.4.4 MidiPrep
    • 9.4.5 MiniPrep
  • 9.5 Viral

10 RNA Isolation and Purification Kits Market (by Source Type) $Million, 2020-2031

  • 10.1 Genomic RNA
    • 10.1.1 Blood
    • 10.1.2 Body Fluids
    • 10.1.3 Cell/Cultured Cell
    • 10.1.4 FFPE
    • 10.1.5 Plant
    • 10.1.6 Saliva/Swab
    • 10.1.7 Serum/Plasma
    • 10.1.8 Tissue
    • 10.1.9 Urine
    • 10.1.10 Others
  • 10.2 Microbial RNA
    • 10.2.1 Bacteria
    • 10.2.2 Yeast
    • 10.2.3 Fungus
    • 10.2.4 Others
  • 10.3 Viral RNA
  • 10.4 Cell-Free RNA
    • 10.4.1 Serum/Plasma
    • 10.4.2 Others

11 Nucleic Acid Isolation and Purification Consumables Market (by Technology), $Million, 2020-2031

  • 11.1 Silica-Based
  • 11.2 Magnetic Particle Technology
  • 11.3 Other Technologies

12 Nucleic Acid Isolation and Purification Consumables Market (by Downstream Applications), $Million, 2020-2031

  • 12.1 PCR
  • 12.2 qPCR
  • 12.3 NGS
  • 12.4 Cloning
  • 12.5 Microarray
  • 12.6 Blotting Techniques
  • 12.7 Other Applications

13 Nucleic Acid Isolation and Purification Consumables Market (by End User), $Million, 2020-2031

  • 13.1 Introduction
  • 13.2 Academic Research Institutes and Laboratories
  • 13.3 Pharmaceutical and Biotechnology Companies
  • 13.4 Contract Research Organizations
  • 13.5 Applied Testing
  • 13.6 Clinical Diagnostic Centers

14 Nucleic Acid Isolation and Purification Consumables Market (by Region)

  • 14.1 North America
    • 14.1.1 U.S.
    • 14.1.2 Canada
  • 14.2 Europe, Middle East & Africa (EMEA)
  • 14.3 Latin America (LATAM)
  • 14.4 Asia-Pacific
    • 14.4.1 China
    • 14.4.2 Japan
    • 14.4.3 Rest-of-APAC

15 Nucleic Acid Isolation and Purification Instrument Market

  • 15.1 Introduction
  • 15.2 Nucleic Acid Isolation and Purification Instrument Market (by Workflow)
    • 15.2.1 Isolation/Extraction/Purification
    • 15.2.2 Quality Control/Quantification
  • 15.3 Nucleic Acid Isolation and Purification Instrument Market (by Technology)
    • 15.3.1 Automated Spin Column-Based Instruments
    • 15.3.2 Magnetic Bead-based Instruments
    • 15.3.3 Automated Liquid Handling Instruments
  • 15.4 Nucleic Acid Isolation and Purification Instrument Market (by Throughput)
    • 15.4.1 Low Throughput Instruments
    • 15.4.2 Medium Throughput Instruments
    • 15.4.3 High Throughput Instruments
  • 15.5 Quality Control/Quantification Instruments (by Technology)
    • 15.5.1 Spectrophotometer
    • 15.5.2 Fluorometers
    • 15.5.3 Others
  • 15.6 Nucleic Acid Isolation and Purification Instrument Market (by End User)
    • 15.6.1 Academic Research Institutes
    • 15.6.2 Pharmaceutical and Biotechnology Companies
    • 15.6.3 Clinical Diagnostic Centers
    • 15.6.4 Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
    • 15.6.5 Contract Research Organizations
  • 15.7 Nucleic Acid Isolation and Purification Instrument Market (by Region)
    • 15.7.1 North America
      • 15.7.1.1 U.S.
      • 15.7.1.2 Canada
    • 15.7.2 Europe, Middle East and Africa
    • 15.7.3 Asia-Pacific
      • 15.7.3.1 China
      • 15.7.3.2 Japan
      • 15.7.3.3 Rest-of-APAC
    • 15.7.4 Latin America

16 Nucleic Acid Isolation and Purification Market Competitive Landscape

  • 16.1 Market Share Analysis (Regional and Global)
    • 16.1.1 Global
    • 16.1.2 North America
    • 16.1.3 EMEA
  • 16.2 Growth Share Matrix by End User
  • 16.3 Growth Share Matrix by Region
  • 16.4 Growth Share Matrix by Products

17 Strategic Recommendations

  • 17.1 Key Takeaways
  • 17.2 Gap Analysis
  • 17.3 Business Expansion Opportunity Mapping
    • 17.3.1 By Product
    • 17.3.2 By Region
  • 17.4 Investment Opportunities
  • 17.5 SWOT Analysis
  • 17.6 Propitious Strategies to Succeed in Nucleic Acid Isolation and Purification Market

18 Company Profiles

  • 18.1 Overview
  • 18.2 Agilent Technologies, Inc.
    • 18.2.1 Company Overview
    • 18.2.2 Role of Agilent Technologies, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 18.2.3 Financials
    • 18.2.4 Key Insights About Financial of the Company
    • 18.2.5 SWOT Analysis
  • 18.3 Analytik Jena AG
    • 18.3.1 Company Overview
    • 18.3.2 Role of Analytik Jena AG in the Global Nucleic Acid Isolation and Purification Market
    • 18.3.3 SWOT Analysis
  • 18.4 AutoGen, Inc.
    • 18.4.1 Company Overview
    • 18.4.2 Role of Autogen, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 18.4.3 SWOT Analysis
  • 18.5 Bio-Rad Laboratories, Inc.
    • 18.5.1 Company Overview
    • 18.5.2 Role of Bio-Rad Laboratories, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 18.5.3 Financials
    • 18.5.4 Key Insights About Financial Health of the Company
    • 18.5.5 SWOT Analysis
  • 18.6 F. Hoffmann-La Roche AG
    • 18.6.1 Company Overview
    • 18.6.2 Role of F. Hoffmann-La Roche AG in the Global Nucleic Acid Isolation and Purification Market
    • 18.6.3 Financials
    • 18.6.4 Key Insights About Financial Health of the Company
    • 18.6.5 SWOT Analysis
  • 18.7 Illumina, Inc.
    • 18.7.1 Company Overview
    • 18.7.2 Role of Illumina, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 18.7.3 Financials
    • 18.7.4 Key Insights About Financial Health of the Company
    • 18.7.5 SWOT Analysis
  • 18.8 Merck KGaA
    • 18.8.1 Company Overview
    • 18.8.2 Role of Merck KGaA in the Global Nucleic Acid Isolation and Purification Market
    • 18.8.3 Financials
    • 18.8.4 Key Insights About Financial Health of the Company
    • 18.8.5 SWOT Analysis
  • 18.9 Meridian Bioscience, Inc.
    • 18.9.1 Company Overview
    • 18.9.2 Role of Meridian Bioscience in the Global Nucleic Acid Isolation and Purification Market
    • 18.9.3 Financials
    • 18.9.4 Key Insights about Financial Health of the Company
    • 18.9.5 SWOT Analysis
  • 18.1 Macherey-Nagel GmbH & Co KG
    • 18.10.1 Company Overview
    • 18.10.2 Role of Macherey-Nagel GmbH & Co KG in the Global Nucleic Acid Isolation and Purification Market
    • 18.10.3 SWOT Analysis
  • 18.11 New England Biolabs, Inc
    • 18.11.1 Company Overview
    • 18.11.2 Role of New England Biolabs, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 18.11.3 SWOT Analysis
  • 18.12 Norgen Biotek Corp.
    • 18.12.1 Company Overview
    • 18.12.2 Role of Norgen Biotek Corp. in the Global Nucleic Acid Isolation and Purification Market
    • 18.12.3 SWOT Analysis
  • 18.13 Omega Bio-tek, Inc.
    • 18.13.1 Company Overview
    • 18.13.2 Role of Omega Bio-tek, Inc., in the Global Nucleic Acid Isolation and Purification Market
    • 18.13.3 SWOT Analysis
  • 18.14 Orasure Technologies, Inc.
    • 18.14.1 Company Overview
    • 18.14.2 Role of Orasure Technologies in the Global Nucleic Acid Isolation and Purification Market
    • 18.14.3 Financials
    • 18.14.4 Key Insights about Financial Health of the Company
    • 18.14.5 SWOT Analysis
  • 18.15 PerkinElmer, Inc.
    • 18.15.1 Company Overview
    • 18.15.2 Role of PerkinElmer, Inc. in the Nucleic Acid Isolation and Purification Market
    • 18.15.3 Financials
    • 18.15.4 SWOT Analysis
  • 18.16 Promega Corporation
    • 18.16.1 Company Overview
    • 18.16.2 Role of Promega Corporation in the Global Nucleic Acid Isolation and Purification Market
    • 18.16.3 SWOT Analysis
  • 18.17 QIAGEN N.V.
    • 18.17.1 Company Overview
    • 18.17.2 Role of QIAGEN N.V. plc in the Global Nucleic Acid Isolation and Purification Market
    • 18.17.3 Financials
    • 18.17.4 Key Insights About Financial Health of the Company
    • 18.17.5 SWOT Analysis
  • 18.18 Sage Science, Inc.
    • 18.18.1 Company Overview
    • 18.18.2 Role of Sage Science, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 18.18.3 SWOT Analysis
  • 18.19 Tecan Group
    • 18.19.1 Company Overview
    • 18.19.2 Role of Tecan Group in the Global Nucleic Acid Isolation and Purification Market
    • 18.19.3 Financials
    • 18.19.4 Key Insights about Financial Health of the Company
    • 18.19.5 SWOT Analysis
  • 18.2 ThermoFisher Scientific Inc.
    • 18.20.1 Company Overview
    • 18.20.2 Role of Thermo Fisher Scientific in the Global Nucleic Acid Isolation and Purification Market
    • 18.20.3 Financials
    • 18.20.4 Key Insights About Financial Health of the Company
    • 18.20.5 SWOT Analysis
  • 18.21 Zymo Research
    • 18.21.1 Company Overview
    • 18.21.2 Role of Zymo Research in the Global Nucleic Acid Isolation and Purification Market
    • 18.21.3 SWOT Analysis
  • 18.22 Emerging Companies